MARY FULGHUM: Open Payments
NPI 1699171967 · MURFREESBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,416 in 53 payments from 19 companies in 2025. Trend: 2023 $2,103 · 2024 $4,172 · 2025 $1,416
Food & beverage: $1,416
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 8 | $211 |
| Lilly USA, LLC | 7 | $189 |
| Dexcom, Inc. | 4 | $187 |
| SANOFI-AVENTIS U.S. LLC | 1 | $112 |
| Sequel Med Tech, LLC | 5 | $106 |
| BETA BIONICS, INC. | 3 | $99 |
| Xeris Pharmaceuticals, Inc. | 3 | $90 |
| ABBVIE INC. | 4 | $78 |
| Madrigal Pharmaceuticals | 2 | $57 |
| IBSA Pharma Inc. | 3 | $49 |
Products named: Dexcom G6 Transmitter, EVENITY, TZIELD, TWIIST, ZEPBOUND, iLet Bionic Pancreas, JARDIANCE, RECORLEV.
Industry payments across TN — which companies pay providers there.
